Ann: CardieX Limited Appendix 4D and Half Year Report, page-35

If ever anyone were choosing their words carefully, this was it.

Also some very pointed comments about Apple, Garmin and Fitbit, what they are and aren't doing, and the opportunity that creates for CDX.

Makes you wonder who the soon-to-announced further partnerships for our own wearable device will be.

Some points of interest.

2.00:

The Mobvoi Smartwatch JV is on track for launch late Q4 FY, so late May early June this year.

We also announced our Home Vital Signs monitor, codenamed The Pulse, which is tracking for Q2FY 22, so late end of this year.

Pulse is the first consumer device for measuring CPB and other clinically relevant parameters targeting both home users and physicians. We think it's going to be incredibly disruptive at both the clinical level and the ecosystem for home user devices.

We have demo units in hand which we are testing, so we're well down the track in that process. We're very excited and gearing up for the launch later this year which we think will be very exciting from the point of view of of having a significant impact on the global health device ecosystem.

5.00: Re CardieX own Wearable Device:

There's nothing been formally announced as of today.

We did lodge a patent last year for our new sensor technology in respect of a new PPG sensor for a wearable device which showed we can extract clinically meaningful health parameters from a PPG sensor. So this is something that no-one's ever been able to do to date. We were able to extract parameters that are equivalent to our FDA cleared Xcel Device.

So it's only natural that we would look to develop a wearable device based on those breakthroughs.

Unlike Apple, Garmin and Fitbit, we're targeting a different and significant market not just in the clinical space, but also with a device that will equally sit in the consumer health space.

Everything we are doing is targeting towards FDA clearance, so unlike Apple, Garmin, Fitbit who continue to play in the same sandpit of consumer devices not really doing anything different in this market in terms of the ecosystem of their own health parameters, we've been able to identify about a dozen significant health parameters that we think are going to be game-changing in the consumer and clinical wearable health space.

So we think we can differentiate ourselves significantly above the levels of data that we can provide in a wearable device, not only targeting consumers, but also the 1.3 billion humans who are at risk of cardiovascular disease.

So expect an announcement on this in the near future, along with details of some further partnerships in that regard.